Table 6.
Post hoc analysis of dependences between patients diagnosed with polysubstance use disorder comorbid with a maniacal syndrome (SUD MANIA)/control and DRD2 rs6276 and NEO FFI Neuroticism scale.
| DRD2 rs6276 and NEO FFI Neuroticism Scale | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| {1} M = 5.52 |
{2} M = 6.02 |
{3} M = 5.08 |
{4} M = 6.19 |
{5} M = 5.83 |
{6} M = 5.60 |
{7} M = 6.05 |
{8} M = 6.67 |
{9} M = 6.47 |
|
| SUD DRD2 rs6276 A/G {1} | 0.0934 | 0.3430 | 0.0888 | 0.4006 | 0.9010 | 0.0539 | 0.0000 * | 0.0102 * | |
| SUD DRD2 rs6276 A/A {2} | 0.0427 * | 0.6791 | 0.6219 | 0.5360 | 0.9340 | 0.0236 * | 0.2380 | ||
| SUD DRD2 rs6276 G/G {3} | 0.0367 * | 0.1454 | 0.4972 | 0.0310 * | 0.0004 * | 0.0068 * | |||
| SUD MANIA DRD2 rs6276 A/G {4} | 0.4407 | 0.4193 | 0.7085 | 0.2095 | 0.54130 | ||||
| SUD MANIA DRD2 rs6276 A/A {5} | 0.7459 | 0.5577 | 0.0220 * | 0.1495 | |||||
| SUD MANIA DRD2 rs6276 G/G {6} | 0.5063 | 0.1120 | 0.2261 | ||||||
| control DRD2 rs6276 A/G {7} | 0.0152 * | 0.2360 | |||||||
| control DRD2 rs6276 A/A {8} | 0.5682 | ||||||||
| control DRD2 rs6276 G/G {9} | |||||||||
*—significant statistical differences, M—mean.